跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POSICAINE-100 INJECTION - HSA Drug Approval Details
Approvals
/
HSA
/
POSICAINE-100 INJECTION
Approved
THERAPEUTIC
POSICAINE-100 INJECTION
NOVOCOL PHARMACEUTICAL OF CANADA INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 10, 2014
Approval ID
e8ea54d668056387
Company
NOVOCOL PHARMACEUTICAL OF CANADA INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
e8ea54d668056387
Drug Name
POSICAINE-100 INJECTION
Product Name
POSICAINE-100 INJECTION
Approval Number
SIN14537P
Approval Date
2014-04-10
Registrant
N.K. LUCK (S) PTE LTD
Licence Holder
N.K. LUCK (S) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
DENTAL
Atc Code
N01BB58
Atc Item Name
articaine, combinations
Pharma Manufacturer Name
n.k. luck (s) pte ltd
Active Ingredients
Epinephrine Bitartrate 0.018mg/ml eqv Epinephrine
0.01mg/ml
Articaine HCl
40mg/ml
ARTICAINE HCL
40 MG/ML
EPINEPHRINE BITARTRATE 0.018 MG/ML EQV EPINEPHRINE
0.01 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 10, 2014
Approval ID
e8ea54d668056387
Type
Therapeutic
Back to HSA Approvals